|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4159217 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22189749.9 |
| Date of filing the European patent application | 2010-10-15 | |
| (97) | Date of publication of the European application | 2023-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-22 |
| (46) | Date of publication of the claims translation | 2024-08-26 |
| (30) | Number | Date | Country code |
| 25221309 P | 2009-10-16 | US |
| (72) |
Dumble, Melissa , US
Kumar, Rakesh , US
Laquerre, Sylvie , US
Lebowitz, Peter , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Derinys, apimantis MEK inhibitorių ir B-Raf inhibitorių |
| COMBINATION COMPRISING AN MEK INHIBITOR AND A B-RAF INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-08-16 | 15 | 289.00 EUR |
| 2025-10-15 |